<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="COI-statement">
 <title>Conflicts of Interest</title>
 <p>This manuscript is not under consideration by another journal, nor has it been published. SGK is a paid consultant-at-large with Oncotelic, Inc., a wholly-owned subsidiary of Mateon Therapeutics, the sponsor for the clinical development of the proprietary formulation of ARTs for SARS-CoV-2 infection. RVR declares no competing financial interests.</p>
</notes>
